Axa
NVRO

Axa’s NEVRO CORP. NVRO Stock Holding History

Axa’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,300
Closed -$294K – 1232
2022
Q3 		$294K Buy
+6,300
New +$292K ﹤0.01% 1044
2020
Q3 		– Sell
-27,100
Closed -$3.24M – 1364
2020
Q2 		$3.24M Sell
27,100
-14,100
-34% -$1.67M 0.01% 726
2020
Q1 		$4.12M Sell
41,200
-11,100
-21% -$1.34M 0.02% 573
2019
Q4 		$6.15M Buy
+52,300
New +$5.18M 0.03% 574
2017
Q1 		– Sell
-25,000
Closed -$1.82M – 1328
2016
Q4 		$1.82M Sell
25,000
-5,500
-18% -$471K 0.01% 780
2016
Q3 		$3.18M Buy
+30,500
New +$2.75M 0.01% 658

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Axa's NVRO Position: Q4 2022 in Review

Axa sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 6,300 shares — an estimated $294K sold.

Axa first reported a position in NVRO in Q3 2016 and held it in 6 quarters. The position peaked at $6.15M in Q4 2019. 169 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Axa reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Axa sold 6,300 NEVRO CORP. shares in Q4 2022, an estimated $294K.
  • Axa first reported a position in NEVRO CORP. in Q3 2016 and held it in 6 quarters.
  • Axa's NEVRO CORP. position peaked at $6.15M in Q4 2019.
  • 169 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.